A phase II, single arm clinical trial involving an alternative
cancer treatment psorinum therapy in patients with
unresectable metastatic colorectal carcinoma.
A phase II, single-arm clinical trial involving an alternative
cancer treatment psorinum therapy in patients with advanced
non-small cell lung cancer (NSCLC).
'' ...... mainstream scientists can’t explain why, so they chalk it
up to the placebo effect. You have to realize a great deal of
so-called science is “parascience” — the people who call the
shots exclude from consideration any evidence that doesn’t fit
what they believe “must” be true. ''